Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gala Health vs VivioMD

By GLP-1 ScorecardUpdated

Gala HealthFactor scores not reassessed.
Site position #11

Higher score

VivioMDFactor scores not reassessed.
Site position #434

Lower score

Score comparison

Gala Health has the higher recorded score — 82.9/100 to 57.4/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Before you choose

VivioMD does not publish a semaglutide price, so its VivioMD review sets out what it does disclose, while the Gala Health review explains the conditions attached to Gala Health's figure. The semaglutide cost page compares published rates across the field. Ask VivioMD for a written total before treating either one as the cheaper choice.

If neither one fits, Gala Health vs Vytora Health and Ro vs VivioMD compare each of them with another graded program, and the list of alternatives to Gala Health ranks the programs closest to Gala Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueGala Health +39
84
45
Dose & formulationGala Health +7
83
76
Clinical oversightGala Health +30
85
55
Labs & monitoringGala Health +30
83
53
FulfillmentGala Health +7
88
81
Contract termsGala Health +37
66
29
Gala Health · top barVivioMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricGala HealthVivioMD
WeighScore82.9/10057.4/100
GradeB−C
Site position#11#434
SemaglutideFrom $69/mo on the annual plan, billed once a year (campaign shows $129/mo; offers conflict—confirm billing term)Not disclosed
TirzepatideFrom $99/mo on the annual plan, billed once a year (campaign shows $179/mo; offers conflict—confirm term)Not disclosed
CoverageCoverage wording differs: all 50 on homepage, most U.S. states in campaignTerms exclude Louisiana; homepage advertises providers in all 50 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Gala Health

Site position #11 · B−

Factor scores not reassessed.

Strengths

  • Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
  • Brand-name Ozempic path and broader menopause/HRT services listed
  • Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking

What to consider

  • Annual-plan and no-contract campaign presentations differ; the lowest prices are advertised as billed once a year
  • Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
  • Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
  • Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer
VivioMD

Site position #434 · C

Factor scores not reassessed.

FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.

Strengths

  • Terms identify OpenLoop clinical groups and list RedRock, Health Warehouse and Triad Rx
  • Public refund policy states the renewal cancellation cutoff

What to consider

  • Reviewed homepage does not show drug-specific pricing
  • Terms exclude Louisiana despite nationwide provider language
  • Cancellation requests must arrive at least 72 hours before the next bill
  • Compounded medications are not FDA-approved

Featured provider

Gala Health

Factor scores not reassessed.

Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard